1370705-39-7 Usage
General Description
3-(Hydroxymethyl)bicyclo[1.1.1]pentane-1-carbonitrile is a chemical compound with the molecular formula C8H9NO. It is a bicyclic compound containing five carbon atoms in a unique ring structure. The presence of a hydroxymethyl group and a carbonitrile group in its structure gives it potential for use in organic synthesis and pharmaceutical research. 3-(Hydroxymethyl)bicyclo[1.1.1]pentane-1-carbonitrile is of interest due to its potential as a building block for the synthesis of more complex molecules and drugs. Additionally, its unique structure and properties make it a valuable target for chemical research and exploration. Further studies are needed to fully understand the potential applications and properties of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1370705-39-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,0,7,0 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1370705-39:
(9*1)+(8*3)+(7*7)+(6*0)+(5*7)+(4*0)+(3*5)+(2*3)+(1*9)=147
147 % 10 = 7
So 1370705-39-7 is a valid CAS Registry Number.
1370705-39-7Relevant articles and documents
Quinuclidine derivative, method for preparing same and application of quinuclidine derivative
-
, (2017/10/13)
The invention relates to a quinuclidine derivative, a pharmaceutically acceptable salt, pro-drug and solvent compound of the quinuclidine derivative, a method for preparing the quinuclidine derivative, a drug composition with the quinuclidine derivative and the pharmaceutically acceptable salt, pro-drug and solvent compound and pharmaceutical application of the quinuclidine derivative. The quinuclidine derivative, the pharmaceutically acceptable salt, pro-drug and solvent compound, the method, the drug composition and the pharmaceutical application have the advantage that the compound is excellent in M3 receptor antagonist activity and accordingly can be used as a novel efficient drug for chronic obstructive pulmonary diseases.
